PKTX · ProtoKinetix, Inc.
Market Cap
$78,316
Shares
391.58M
PKTX metrics
42 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.00
Market cap
$78,316
Price action
19 metricsPrice change (1W)
+0.0%
Price change (30D)
-97.1%
Price change (3M)
-96.2%
Price change (6M)
-97.0%
Price change (YTD)
-96.7%
Price change (1Y)
-97.2%
Trailing year
Price change (5Y)
-99.8%
52-week high
$0.01
52-week low
$0.00
Change from 52-week high
-98.0%
Change from 52-week low
+100.0%
Annualized volatility
8,909.8%
Beta
179.4
RSI (14D)
39.0
Price vs SMA 50
-96.1%
Price vs SMA 200
-96.9%
Avg volume (3M)
119,148
Relative volume
0.1
Average dollar volume
$523
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
391.58M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.3
reciprocal yield 319.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-480.3%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
−$376,176
Trailing 12 months
Diluted EPS (TTM)
$0.00
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+6.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-150.2%
Return on assets
-78.8%
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$607
Total assets
$477,623
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$181,177
Capital expenditures (TTM)
—
R&D (TTM)
$103,393
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
1
13F filer change QoQ
0
Institutional ownership
0.0%
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—